About this episode

Dr. Franziska Ippen interviews Dr. David Schiff about the findings of the CATNON study regarding chemotherapy in IDHmt Grade 3 Astrocytoma.

Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: David Schiff Podcast Description: Dr. Franziska Ippen interviews Dr. David Schiff on his recent manuscript entitled "CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma"

More episodes of Neuro-Oncology: The Podcast

• Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial · June 1, 2026 · 29 min
• Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma · May 29, 2026 · 3 min
• Author Interview Series SNO Podcast May 2026 · May 25, 2026 · 16 min
• Neuro-Oncology Narrative · May 18, 2026 · 34 min
• Hot Topics: Wellness in Neuro-oncology · May 15, 2026 · 25 min
• Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma · May 11, 2026 · 4 min

Explore listener stats, chart rankings, contacts and more on the Neuro-Oncology: The Podcast podcast page.